HSBC Continental Europe: Post Stabilisation Notice

PARIS, July 01, 2025 (GLOBE NEWSWIRE) --

 Post Stabilisation Notice

HSBC (contact: [email protected]) hereby gives notice that no stabilisation was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

You May Also Be Interested In

• First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
• Hepatic Encephalopathy Therapeutics Market Size in the 7MM is projected to grow at a CAGR of ~1.5% over the forecast period of 2026-2042 | DelveInsight
• Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records